ClinicalTrials.gov
ClinicalTrials.gov Menu

Concentration and Activity of Lapatinib in Vestibular Schwannomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00863122
Recruitment Status : Unknown
Verified August 2013 by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Recruitment status was:  Recruiting
First Posted : March 17, 2009
Last Update Posted : August 7, 2013
Sponsor:
Collaborators:
The Children's Tumor Foundation
GlaxoSmithKline
New York University
Ohio State University
House Research Institute
Washington University School of Medicine
Weill Medical College of Cornell University
Massachusetts General Hospital
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2013
  Study Completion Date : No date given

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 4, 2017
February 23, 2017
2 March 20, 2017
April 28, 2017
3 May 31, 2017
January 5, 2018
4 May 21, 2018